1,057
Views
27
CrossRef citations to date
0
Altmetric
Original papers

Temporal and spatial expression of BMP-2 in sub-chondral bone of necrotic femoral heads in rabbits by use of extracorporeal shock waves

, , &
Pages 98-105 | Received 15 Jun 2007, Accepted 07 Oct 2007, Published online: 08 Jul 2009

Figures & data

Figure 1. Photomicrographs of subchondral bone immu-nostained with anti-BMP-2. A. Subchondral bone of the necrotic femoral heads untreated with shock waves: slight BMP-2 immunoreactivity (BMP-2-IR) was found in osteo-blasts and fibroblastic cells. B. 4 weeks after application of shock waves, the osteoblasts and the fibroblastic cells showed an increased level of BMP-2-IR. C. 8 weeks after shock wave application, BMP-2-IR was increased in the fibroblastic cells of the vascular granulation tissue invading the necrotic bone. Bone matrix also showed BMP-2-IR. D. 12 weeks after shock wave application, BMP-2-IR was observed in the trabecular bone and the marrow. Osteoblasts adjacent to the newly formed woven bone showed intensive expression of BMP-2. E. BMP-2-IR was absent when the primary antibody was replaced with PBS or non-immune mouse serum. (All images ×200).

Figure 1. Photomicrographs of subchondral bone immu-nostained with anti-BMP-2. A. Subchondral bone of the necrotic femoral heads untreated with shock waves: slight BMP-2 immunoreactivity (BMP-2-IR) was found in osteo-blasts and fibroblastic cells. B. 4 weeks after application of shock waves, the osteoblasts and the fibroblastic cells showed an increased level of BMP-2-IR. C. 8 weeks after shock wave application, BMP-2-IR was increased in the fibroblastic cells of the vascular granulation tissue invading the necrotic bone. Bone matrix also showed BMP-2-IR. D. 12 weeks after shock wave application, BMP-2-IR was observed in the trabecular bone and the marrow. Osteoblasts adjacent to the newly formed woven bone showed intensive expression of BMP-2. E. BMP-2-IR was absent when the primary antibody was replaced with PBS or non-immune mouse serum. (All images ×200).

Figure 2. Gene expression of BMP-2 in shock wave-treated femoral heads (red bars) and in untreated femoral heads (blue bars) at 24 h and 1, 2, 4, 8, and 12 weeks after the application of shockwave treatment, as determined by realtime quantitative RT-PCR.The graph demonstrates the fold change (and range) for each experimental group when the untreated femoral head of 24 h was normalized to 1. The asterisks indicate statistically significant differences between shock wave-treated femoral heads and untreated femoral heads at the indicated time point. SW: shock wave-treated femoral head; control: untreated femoral head.

Figure 2. Gene expression of BMP-2 in shock wave-treated femoral heads (red bars) and in untreated femoral heads (blue bars) at 24 h and 1, 2, 4, 8, and 12 weeks after the application of shockwave treatment, as determined by realtime quantitative RT-PCR.The graph demonstrates the fold change (and range) for each experimental group when the untreated femoral head of 24 h was normalized to 1. The asterisks indicate statistically significant differences between shock wave-treated femoral heads and untreated femoral heads at the indicated time point. SW: shock wave-treated femoral head; control: untreated femoral head.

Figure 3. A. Western blot analysis of subchondral bone samples obtained from necrotic femoral heads at 24 h and 1, 2, 4, 8, and 12 weeks after the application of shock-wave treatment. (Lanes 24h, 1wk, 2wks, 4wks, 8wks and 12wks represent 24 hours and 1, 2, 4, 8, and 12 weeks, respectively). Western blot analysis consistently showed increased BMP-2 expression at 1, 2, 4, and 8 weeks compared to the samples from the untreated control femoral heads. B. Graph showing densitometric analysis of western blot, normalized to the density of β-actin in each lane. The asterisks indicate statistically significant differences between shock wave-treated femoral heads and untreated femoral heads at each time point. SW: shock wave-treated femoral head. Control: untreated femoral head.

Figure 3. A. Western blot analysis of subchondral bone samples obtained from necrotic femoral heads at 24 h and 1, 2, 4, 8, and 12 weeks after the application of shock-wave treatment. (Lanes 24h, 1wk, 2wks, 4wks, 8wks and 12wks represent 24 hours and 1, 2, 4, 8, and 12 weeks, respectively). Western blot analysis consistently showed increased BMP-2 expression at 1, 2, 4, and 8 weeks compared to the samples from the untreated control femoral heads. B. Graph showing densitometric analysis of western blot, normalized to the density of β-actin in each lane. The asterisks indicate statistically significant differences between shock wave-treated femoral heads and untreated femoral heads at each time point. SW: shock wave-treated femoral head. Control: untreated femoral head.

Figure 4. A. Under epifluorescent light, the tetracy-cline labels in shock wave-treated femoral heads were intense and the distances between two lines were wide (×100). B. Under epifluorescence, the tetracycline labels in untreated femoral head were weak and the distances between two lines were narrow (×100). C. Graph showing the calcification deposition rate of shock wave-treated femoral heads (red bars) and untreated femoral heads (blue bars). The asterisks indicate statistically significant differences between shock wave-treated femoral heads and untreated femoral heads at each time point. SW: shock wave-treated femoral head; control: untreated femoral head.

Figure 4. A. Under epifluorescent light, the tetracy-cline labels in shock wave-treated femoral heads were intense and the distances between two lines were wide (×100). B. Under epifluorescence, the tetracycline labels in untreated femoral head were weak and the distances between two lines were narrow (×100). C. Graph showing the calcification deposition rate of shock wave-treated femoral heads (red bars) and untreated femoral heads (blue bars). The asterisks indicate statistically significant differences between shock wave-treated femoral heads and untreated femoral heads at each time point. SW: shock wave-treated femoral head; control: untreated femoral head.

Figure 5. Histological findings in the femoral head following injection of methylprednisolone and lipopolysaccharide in rabbits. Mid-coronal section from rabbit femoral head 6 weeks after the injection, stained with hematoxylin-eosin. A. Marrow necrosis (x100). B. Trabecular necrosis (x200). C. Trabecular necrosis and dense medullary fibrosis (x100).

Figure 5. Histological findings in the femoral head following injection of methylprednisolone and lipopolysaccharide in rabbits. Mid-coronal section from rabbit femoral head 6 weeks after the injection, stained with hematoxylin-eosin. A. Marrow necrosis (x100). B. Trabecular necrosis (x200). C. Trabecular necrosis and dense medullary fibrosis (x100).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.